| Labcorp

September 30, 2021

Reuters Event - Cell & Gene Therapy USA - Taking the Long View: Addressing the Unique Challenge of Long-Term Follow Up for Cell & Gene Therapies

Listen to Maryland Franklin, PhD, Vice President and Enterprise Head of Cell & Gene Therapy, Labcorp Drug Development, focus on addressing the complexity of long-term follow up for cell and gene therapy with a patient-guided approach in her presentation, Taking the Long View: Addressing the Unique Challenge of Long-Term Follow Up for Cell & Gene Th

October 7, 2021

Precision Medicine in Autoimmune Disorders: From Drug Development to Diagnostics Webinar

Explore the emerging role of precision medicine approaches for the treatment of autoimmune disorders.

October 20, 2021

Webinar: Lessons Learned - A Practical Perspective on Cystic Fibrosis Clinical Trials

The webinar covers the current lessons learned from recent CF trials, barriers faced in today's research landscape, and several approaches to handle common issues.

October 27, 2021

Breast Cancer Biomarkers: The Emerging Role of Immune and Digital Biomarkers and the Benefits of Parallel CDx Development

How do you identify the right patient for a given drug? How do you select your population to ensure that the signal of benefit is most pronounced? The boundaries of breast cancer biomarker development are being increasingly pushed to help power better decisions for developers, oncologists and, ultimately, for breast cancer patients.

October 27, 2021

Accelerated First in Human Trial of a Promising SARS-CoV-2 Antiviral

The critical need for potent SARS-CoV-2 treatments has required acceleration of development timelines without compromising safety. Learn how one biotech company was able to administer the first human dose of a new antiviral just 23 days after first meeting with the CRO.

October 28, 2021

Roundtable: Accelerating CAR T Development from Preclinical to Clinical Utilizing Key Biomarker Insights

From revealing phenotypic and functional characterization of CAR T-cell products, along with mechanistic markers of efficacy and predictive markers of safety and response, biomarkers of all types play a central role in delivering critical insights that support informed decisions at every step of therapeutic development.

October 29, 2021

Addressing Challenges and New Developments in Endometriosis Clinical Research

Over the last decade, an increasing number of drug development sponsors have conducted endometriosis clinical trials to explore more specific therapeutic targeting approaches for this chronic disease.

November 1, 2021

Labcorp Stool Sample Case Study Video

This video outlines challenges faced in the studies and helped streamline all aspects of the education, support, collection and shipment processes of biological samples.

November 2, 2021

Digital Pathology Solutions for Drug Development and Diagnostics

There has been a growing body of supporting evidence in the translational research field showing the role genomic- and proteomic-based platforms in enabling more informed and potentially effective therapeutic strategies in clinical development and when appropriate transitioning to diagnostic applications. Hear from Labcorp Drug Development Sr.

November 3, 2021

Advancing Meaningful Remote Digital Endpoints for Rare Disease Clinical Trials

Looking to better assess treatment benefit, drug developers for rare diseases are eager to incorporate remote monitoring solutions to complement the "snapshot" data collected at clinical visits and to collect richer data on how patients function at home.

Managing Your Health

Diseases & Therapeutic Areas

Treatment Modalities & Methods

Scientific Lab Disciplines

Labs

Industries